# Haematologic Technologies, LLC dba Prolytix - Inspection Records

Source: https://www.keypedia.com/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed

> Inspection records and compliance data for Haematologic Technologies, LLC dba Prolytix in Essex Junction, Vermont. Access full analysis and detailed observations.

---

## Details

- Name: Haematologic Technologies, LLC dba Prolytix
- FEI Number: 3010163994
- City: Essex Junction
- State: Vermont
- Country Name: United States
- Address Line 1: 57 River Rd Unit 1010
- Zip Code: 05452

## Related Documents

- [FDA Inspection 1314930 - Haematologic Technologies, LLC dba Prolytix - 2026-04-17](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/0542f691-8e6c-4a69-b14f-629cd185c8ad) — source: FDA, date: April 17, 2026
- [FDA Inspection 1258523 - Haematologic Technologies, LLC dba Prolytix - 2025-01-06](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/2bd126ff-88fd-4f0c-b960-123053dbc85c) — source: FDA, date: January 6, 2025
- [483 - Haematologic Technologies, LLC dba Prolytix - 2021-07-30](https://www.keypedia.com/records/483/haematologic-technologies-llc-dba-prolytix/a561a2e6-e6dc-4360-a63a-015dd6a9a2ca) — source: FDA, date: July 30, 2021
- [FDA Inspection 1147450 - Haematologic Technologies, LLC dba Prolytix - 2021-07-30](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/dd1f1270-2289-4dff-acb7-884da6a6a1cc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2021
- [FDA Inspection 1098078 - Haematologic Technologies, LLC dba Prolytix - 2019-06-27](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/50ca8d3d-8097-4872-aed7-441384aec950) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2019
- [483 - Haematologic Technologies, LLC dba Prolytix - 2019-06-25](https://www.keypedia.com/records/483/haematologic-technologies-llc-dba-prolytix/db36ede5-1f24-42eb-ad4d-6269ad163601) — source: FDA, date: June 25, 2019
- [FDA Inspection 1027695 - Haematologic Technologies, LLC dba Prolytix - 2017-07-28](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/9b2964a1-23ba-4602-8250-6d224de178bd) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2017
- [483 - Haematologic Technologies, LLC dba Prolytix - 2017-05-11](https://www.keypedia.com/records/483/haematologic-technologies-llc-dba-prolytix/aea0025e-2196-4a23-bc0c-9adb9107d7cf) — source: FDA, date: May 11, 2017
- [FDA Inspection 1013147 - Haematologic Technologies, LLC dba Prolytix - 2017-05-11](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/c6e6dd3e-5093-458a-9a69-6b09b1f005a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2017
- [FDA Inspection 887848 - Haematologic Technologies, LLC dba Prolytix - 2014-06-26](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/4bdaa7a4-e966-4a70-ae91-a3f0f5e7a337) — classification: No Action Indicated (NAI), source: FDA, date: June 26, 2014

## Related Companies

- [Emergent Biosolutions LLC](https://www.keypedia.com/companies/emergent-biosolutions-llc/a4e71e63-5d44-4dd7-a589-a755c72b0637)
- [Charles River Laboratories, Inc.](https://www.keypedia.com/companies/charles-river-laboratories-inc/b007c718-aa18-4f77-84ea-4d96765ed0e6)
- [Supernus Pharmaceuticals, Inc.](https://www.keypedia.com/companies/supernus-pharmaceuticals-inc/eff1a996-667f-4888-9fd8-50ca50265d74)
- [Chiesi Farmaceutici S.p.A.](https://www.keypedia.com/companies/chiesi-farmaceutici-spa/c5c5e25e-4e01-482a-b5b3-7a7b11458a67)
- [Associates of Cape Cod, Inc.](https://www.keypedia.com/companies/associates-of-cape-cod-inc/c3c3c25d-3eec-4ab0-826d-a9c915ae89d2)
- [Alcami Carolinas Corporation](https://www.keypedia.com/companies/alcami-carolinas-corporation/bc876747-1f37-4ea6-9e86-c152c19f219e)
- [Bioreliance Corporation](https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000)
- [ALS Group USA, Corp](https://www.keypedia.com/companies/als-group-usa-corp/6d3305d4-76a4-4d57-8ed6-1e636d486309)
- [Encompass Pharmaceutical Services Inc.](https://www.keypedia.com/companies/encompass-pharmaceutical-services-inc/42c093ab-f3bc-421b-8622-2450df89f843)
- [Element Materials Technology Boston - Acton Inc.](https://www.keypedia.com/companies/element-materials-technology-boston-acton-inc/24258d5a-8309-4e67-90f1-adda6124441c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)
- [Jason D Abel](https://www.keypedia.com/people/jason-d-abel/42c4bafe-17bb-4a43-80cd-83dd77b3426d)
- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Principal Consultant- CMC Biologics, Former FDA regulator with expertise in CMC and GMP for Biologics](https://www.keypedia.com/people/steven-e-bowen/0e32c7e6-285b-4cf1-90e1-8a7a12a38b0c)